Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
07/2006
07/20/2006CA2594680A1 Production method of optically active cyclohexane ether compounds
07/20/2006CA2592969A1 New one-step synthesis of useful disubstituted amines
07/19/2006EP1680406A1 N-substituted benzene sulfonamides
07/19/2006EP1680400A2 Derivatives of n-[ phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[ (azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
07/19/2006EP1680395A2 Novel ligand activating receptors rars used for human medicine and cosmetics
07/19/2006EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/19/2006EP1268453B1 Estrogen agonist/antagonist metabolites
07/19/2006CN1805935A Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
07/19/2006CN1805929A Phosphodiesterase 4 inhibitors
07/19/2006CN1805928A Prodrugs of mitotic kinesin inhibitors
07/19/2006CN1805927A 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists
07/19/2006CN1803797A Inhibitors of dipeptidyl peptidase IV
07/19/2006CN1803760A N-arylation process with hydrazone as ligand in aqueous phase system
07/18/2006USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals
07/18/2006US7078567 Forming c-n bonds; isomerization
07/18/2006US7078537 Phenylalkyl diamine and amide analogs
07/18/2006US7078535 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
07/18/2006US7078430 3-carbamoyl-pyran that is n-derivatized by dihydroxyheptanoic acid or 6-ethyl-4-hydroxy-pyran-2-one; anticholesterol agents
07/18/2006US7078424 Central nervous system disorders; alopecia
07/18/2006US7078421 Substituted phenylacetic acids
07/18/2006US7078407 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them
07/18/2006US7078114 Phosphorescence compound and electro field light emitting device having the same
07/18/2006US7076902 Firing system for a firearm
07/18/2006CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/18/2006CA2325781C New amino pyrrolin compounds, their preparation process and the pharmaceutical compositions therein
07/18/2006CA2224528C Stilbene compositions in the adamantyl group, compositions containing them and uses
07/13/2006WO2006074244A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/13/2006WO2006073367A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators
07/13/2006WO2006073167A1 Pyrrolidine derivatives
07/13/2006WO2006073112A1 Metal complex compound and organic electroluminescent element using the same
07/13/2006WO2006048893A3 A process for synthesis of large particle size statin compounds
07/13/2006WO2006042478A8 Small-molecule inhibitors of coronaviral main protease, their preparation and use
07/13/2006US20060155140 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors
07/13/2006US20060155121 Substituted aniline derivatives
07/13/2006US20060155078 rubber crosslinking agent which exhibits excellent storage stability and heat resistance; a compound having a thiol group protected by a maleimide compound and an active hydrogen-containing group; rubber laminate
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/13/2006US20060154922 Muscarinic agonists
07/13/2006US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
07/13/2006CA2594098A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/12/2006EP1679301A1 Esters of nonsteroidal anti-inflammatory drugs and methods of their preparation
07/12/2006EP1678167A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
07/12/2006EP1678134A1 Preparation of 4,5-dialkyl-3-acyl-pyrrole-2-carboxylic acid derivatives by fischer-fink type synthesis and subsequent acylation
07/12/2006EP1678132A1 Process for the production of lactams
07/12/2006EP1678121A2 Tao kinase modulators and methods of use
07/12/2006EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction
07/12/2006CN1802366A C-glycoside derivatives and salts thereof
07/12/2006CN1802362A Quaternary ammonium salt, electrolyte, and electrochemical device
07/12/2006CN1802352A Process for producing levetiracetam
07/12/2006CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
07/12/2006CN1800162A N-protective ertapenem intermediate preparation method
07/12/2006CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels
07/11/2006US7074940 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline forms
07/11/2006US7074831 Autoimmune diseases; antiinflammatory agents; graft versus host disease; anticancer agents; antiarthritic agents
07/11/2006US7074818 Anticholesterol agents; reacting atorvastatin with calcium acetate; salt formation; heating; filtration; distillation
07/11/2006US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor
07/11/2006US7074785 Δ1-pyrrolines used as pesticides
07/11/2006CA2364718C Monoamine reuptake inhibitors for treatment of cns disorders
07/11/2006CA2269810C N-substituted 2-cyanopyrrolidines
07/11/2006CA2206532C Novel amidinonaphthyl derivative or salt thereof
07/11/2006CA2168447C Compounds and methods for inhibition of hiv and related viruses
07/06/2006WO2006071958A1 Compounds useful as chemokine receptor antagonists
07/06/2006WO2006070878A1 Carboxylic acid derivative or salt thereof
07/06/2006WO2006070284A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
07/06/2006WO2006069808A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
07/06/2006WO2006069656A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation
07/06/2006WO2006069441A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases
07/06/2006WO2006052893A3 Substituted pyrrolidone compounds as ep4 agonists
07/06/2006US20060149092 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
07/06/2006US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents
07/06/2006US20060145151 Transferring electric charging; coloring; ion permselective films used for display; comprises transition metal (for example, silver ion) as central atom, and basic ligands comprised of 5-membered heterocyclic aromatic compound (for example, pyrrole rings), in which position of central atom can be changed
07/06/2006DE102004060654A1 Verfahren zur Reinigung eines Apparates von Ablagerungen aus einem Verfahren zur Rückgewinnung von NMP A method for cleaning an apparatus of deposits from a process for the recovery of NMP
07/06/2006CA2594251A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
07/06/2006CA2592852A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
07/06/2006CA2592430A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation
07/05/2006EP1676842A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
07/05/2006EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
07/05/2006EP1675832A1 Heterocyclyl compounds
07/05/2006EP0918514B9 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
07/05/2006CN1796371A Dicationic bis-hydrazone compound, dye composition comprising at least one such compound, implementation process therefor and uses thereof
07/04/2006US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents
07/04/2006US7071338 Process for the synthesis of bis-aryl diamidoxime compounds
07/04/2006US7071224 Antihistamines; bronchodilator agents; respiratory system disorders
07/04/2006US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives
07/04/2006US7071211 Vision disorders; adjustment activation of gelatinase
07/04/2006US7071191 Non-imidazole aryloxypiperidines
07/04/2006US7071177 P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents
07/04/2006US7070626 Oxidative coloring agents for keratin fibers
06/2006
06/29/2006WO2006068992A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
06/29/2006WO2006068991A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
06/29/2006WO2006067472A1 Parp inhibitors
06/29/2006WO2006066978A1 Novel ligands that modulate rar receptors, and use thereof in human medicine and in cosmetics
06/29/2006WO2006066896A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
06/29/2006WO2006066823A1 Process for preparing pyrrole derivatives and intermediates
06/29/2006WO2006066790A1 Tetralin and indane derivatives and uses thereof
06/29/2006WO2006066770A1 Cycloalkylamine derivatives
06/29/2006WO2006060390A1 Quinoline tachykinin receptor antagonists
06/29/2006WO2006055565A3 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives
06/29/2006WO2006044446A3 Organometallic compounds and processes for preparation thereof
06/29/2006WO2006035157A3 Substituted n-(benzyl)phenylacetamide derivative compounds, preparation method thereof and uses of same as ppar ligands in the treatment of lipid and/or glucidic disorders
06/29/2006US20060142612 Arylsulfonamide derivatives